- 20 minutes 5 secondsEvolution of MR Contrast Agents- Sponsored by GE HealthCare
Dr. Linda Chu welcomes Dr. Robert McDonald (Mayo Clinic) and Dr. Paul Evans (GE HealthCare) for a discussion on the evolution of MR contrast agents, exploring how gadolinium has changed MRI diagnostics and what decades of clinical experience have taught the radiology community. The conversation also looks ahead to emerging contrast technologies, including iron and manganese based agents and other innovations that could shape the future of MR imaging, safety, and sustainability.
Sponsored by GE HealthCare
8 October 2026, 5:40 pm - 26 minutes 30 secondsBridging the Gap in Breast Imaging
Dr. Reni Butler speaks with Dr. Bryan Haslam, Dr. Greg Sorensen, Dr. Matt McCabe, and Dr. Christoph Lee about their large real-world study evaluating an AI driven workflow for screening mammography across 109 U.S. facilities. Together, they explore how AI helped general radiologists achieve cancer detection and recall performance comparable to breast imaging specialists, as well as the broader implications for patient care, workflow design, and the future of precision screening.
22 September 2026, 2:00 pm - 41 minutes 45 secondsStandardized Knee Meniscus MRI Reporting -Sponsored by GE HealthCareHost Dr. Linda Chu sits down with Dr. Jie Nguyen, Dr. Todd Lawrence, and Dr. Kirk Davis to discuss an interdisciplinary consensus on standardized knee meniscus MRI reporting and the terminology that improves communication between radiologists and orthopedic surgeons. Together, they explore MRI criteria for meniscus tears, reporting best practices, surgical implications, post operative assessment, and how consistent language can enhance patient care and clinical decision making. Standardized Knee Meniscus MRI Reporting: An Interdisciplinary Delphi Consensus. Nguyen et al. Radiology 2026; 319(3):e251833. Sponsored by GE HealthCare15 September 2026, 2:00 pm
- 22 minutes 45 secondsProstate Cancer EMPIRE 2 Findings
Dr. Ashwin Parihar speaks with Dr. Olayinka A. Abiodun-Ojo and Dr. David M. Schuster about findings from the EMPIRE 2 trial, exploring how fluciclovine PET and PSMA PET influence salvage radiotherapy planning for men with recurrent prostate cancer after prostatectomy. The discussion examines the strengths and limitations of each tracer, the importance of prostate bed detection, and where fluciclovine may still have a role in the evolving era of PSMA-targeted imaging.
8 September 2026, 2:00 pm - 26 minutes 30 secondsRadiology ReimaginedIn this episode of the Radiology Podcast, Dr. Siddhant Dogra speaks with Dr. Albert Jiao about Radiology Reimagined and the critical role interoperability plays in integrating AI into everyday radiology workflows. Together, they explore lessons learned from large-scale AI demonstrations, practical considerations for evaluating imaging AI tools, and what the future of radiology innovation may look like. Radiology Reimagined: Interoperability and Lessons Learned from the Imaging AI in Practice Demonstration. Jiao et al. Radiology 2026; 319(3):e252225.25 August 2026, 2:00 pm
- 28 minutes 31 secondsQuantifying Energy Consumption in MRI, CT, and PET/CT
Dr. Lauren Kim speaks with first author Dr. Andrew Hernandez about his study which comprehensively quantified energy consumption in MRI, CT, and PET/CT imaging suites by measuring the energy utilization of main power, HVAC, and chilled water subsystems. The study showed that HVAC and chilled water subsystems contribute substantially to total energy consumption, that energy efficiency increases with increasing daily scanning volume, and that a substantial portion of energy consumption occurs during non-operating hours.
Quantification of Imaging Suite–Level Energy Patterns in MRI, CT, and PET/CT to Guide Energy Efficiency. Hernandez et al. Radiology 2026; 319(1):e253128.18 August 2026, 2:00 pm - 21 minutes 48 secondsAI and Breast Cancer PredictionHost Dr. Reni Butler sits down with Dr. Connie Lehman to discuss groundbreaking research on how AI-generated breast cancer risk scores change over time and what those changes may reveal about a woman's future cancer risk. Together, they explore the promise of longitudinal imaging biomarkers, personalized screening strategies, and how artificial intelligence could transform breast cancer detection and prevention. Longitudinal Analysis of Changes in Deep Learning Image-based Breast Cancer Risk Scores over Time. Lehman et al. Radiology 2026; 319(3):e253023.11 August 2026, 2:00 pm
- 19 minutes 29 secondsAir Pollution Heart RiskDr. Refky Nicola welcomes back Dr. Kate Hanneman to discuss new research examining the link between long-term air pollution exposure and coronary atherosclerosis detected on cardiac CT. Together, they explore key findings on plaque burden, sex-specific differences, cumulative exposure risks, and the growing cardiovascular implications of wildfire smoke. Sex-Specific Associations between Long-term Air Pollution Exposure and Coronary Atherosclerosis at Cardiac CT. Castillo et al. Radiology 2026; 319(3):e252086.4 August 2026, 2:00 pm
- 28 minutes 33 secondsConsensus in Diagnosing Fibrotic Interstitial Lung Disease
Dr. Lauren Kim and first author Dr. Daniel Marinescu discuss this study comprised of approximately 1,500 patients which determines the relative importance of specific CT imaging features used to distinguish radiologic patterns in fibrotic interstitial lung disease. This study identifies areas of substantial incongruence between radiologist-assigned ILD patterns and current clinical diagnostic guideline definitions, incongruencies which in turn may help refine and standardize future diagnostic criteria.
From CT Features and Patterns to Clinical Pathways: Focusing a Multinomial Lens on Fibrotic ILD. Czum and Brown. Radiology 2026; 318(3):e260494.
28 July 2026, 2:00 pm - 17 minutes 7 secondsHow CT-based Screening Is Redefining PreventionHost Dr. Celina Nahyun Jo sits down with Dr. Perry Pickhardt to explore how opportunistic CT screening is transforming routine imaging into a powerful tool for cardiometabolic risk assessment, bone health evaluation, liver disease detection, and body composition analysis. Together, they discuss the role of explainable AI, the future of CT-based biologic age, and why value-added imaging has the potential to reshape preventive care. CT-based Opportunistic Screening for Adding Clinical Value:How I Do It. Pickhardt et al. Radiology 2026; 319(1):e252106.21 July 2026, 2:00 pm
- 35 minutes 7 secondsOptimizing Radiography UtilizationDr. Linda Chu speaks with Dr. Eddy Zandee and Dr. Kirk Davis about multidisciplinary expert consensus recommendations aimed at reducing the use of low yield radiographs and improving imaging appropriateness across healthcare settings. They explore which common radiographic exams may offer limited clinical value, when CT or MRI may be more appropriate, and how education and workflow changes can help optimize imaging utilization. Optimizing Radiography Utilization: Multidisciplinary Expert Consensus Recommendations Endorsed by the Society of Academic Bone Radiologists, Society of Skeletal Radiology, American Societyof Emergency Radiology, Orthopaedic Trauma Association, American Academy of Emergency Medicine, and American Rhinologic Society. Zandee van Rilland et al. Radiology 2026; 319(2):e252309.14 July 2026, 2:00 pm
- More Episodes? Get the App